Delivery Order SPE2DB20D3103-SPE2DB24FN1V3
Award Date 3/26/24
Potential Completion Date 3/27/24
Potential Value $4.9K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00. The contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The current delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,922.72, is for the delivery of 4,564,361,217 units of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. This contract has a completion date of April 23, 2024 and is a firm fixed-price arrangement. The IDC held by Cencora, Inc. with the DLA is...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support military and veteran healthcare programs. The contract has a period of performance through April 28, 2023, with a ceiling value of $41,809.10....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $8,936.50 delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through January 24, 2024. The parent IDC held by Cencora, Inc. is valued at up to $999,999,999.00 and runs through December 31, 2025. This...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $24,902.60 for the supply of NURTEC ODT 75 MG TABLET 8S medical products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of February 1, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $24,745.08 for the supply of Nurtec ODT 75 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of April 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $35,945.92 for the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 7, 2024. The contract is a Firm Fixed Price Delivery Order and was not set aside for any specific business type. Amerisourcebergen Drug Corp, as the prime contractor, will be responsible...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides $22,536.03 for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of August 6, 2021 and was awarded on August 5, 2021. This award is not designated as a set-aside contract. The IDC held by...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $15,588.36 and is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $2,342.24, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order to supply the pharmaceutical product NURTEC ODT 75 MG TABLET 8S. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
Teaming
Find teaming partners for this award
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN1V3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order under the Defense Logistics Agency's (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00 through November 2026. The award covers the delivery of 4,564,082,897 units of the medication NURTEC ODT 75 MG TABLET 8S, with a ceiling value of $4,916.31 and a completion date of March 27, 2024. This contract supports the DLA's procurement of essential pharmaceutical products, including specialty medications, brand-name drugs, and generic pharmaceuticals, to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries. The award is not designated with a set-aside.
Generated 2/27/25, 11:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 3/26/24 |